Interested in joining our research group?

We have currently several Honours, Masters and PhD positions available in the our research group. For more information, email markus.hofer@sydney.edu.au

Current project AREAS

 
red-blood-cells-3188223_1920.jpg

 TARGETING THE BRAIN VASCULATURE AS A TREATMENT FOR CEREBRAL TYPE I INTERFERONOPATHIES

Abnormal blood vessels are feature of cerebral type I interferonopathies. Discover how the endothelial cells that line the brain’s blood vessels contribute to disease in patients with cerebral type I interferonopathies.


 
pawel-czerwinski-JdtUKqGdqw8-unsplash%2B%25281%2529.jpg

THE PATHOGENIC AND PROTECTIVE EFFECTS OF MICROGLIA IN CEREBRAL CYTOKINOPATHIES

Microglia are the primary immune cells of the brain and have the potential to both protect and contribute to neurological disease. Explore the molecular mechanisms that microglia use to mediate their biological effects in cerebral cytokinopathies.


 
robina-weermeijer-3KGF9R_0oHs-unsplash.jpg

HOW DIFFERENT CELL TYPES OF THE BRAIN CONTRIBUTE TO CEREBRAL CYTOKINOPATHIES

The brain consists of a large number of different cell types, including neurons, astrocytes, oligodendrocytes, microglia and endothelial cells. Discover how these different cell types mediate the pathogenesis of cerebral cytokinopathies using transgenic mouse models.